Biotech Stocks to Buy: Sinovac Biotech (SVA)
Sinovac Biotech LTD (SVA) is a Chinese biotech company that makes drugs to treat conditions such as hepatitis A, hepatitis B, and influenza viruses. The just announced that the phase three trials of a new drug to fight a virus called EV-71 that causes neurological conditions such hand foot and mouth disease showed great promise. Phase III trial results EV71 vaccine show that the drug had a 94.8% efficacy rate against EV71-related hand, foot, and mouth disease, and a 100% efficacy rate against EV71-associated hospitalization and against HFMD with neurologic complications.
Sinovac also just filed an application for human trials in China for a vaccine against avian flu. Profits more than doubled in their latest report and the stock receives an A form Portfolio Grader.
SVA is a strong buy at the current price.